Finch 3 trial in MTX naive pts shows that mono Rx FIL 200=MTX mono for ACR20 but FIL200 superior for ACR50/70. 200mg works faster with more big responders early. Drs. Fleischman/Genovese at #RWCS2020 @RWCSmtg https://t.co/msgB6DS5cl

Finch 1 trial of Filgotinib vs adalimulmab in MTX IR #RA pts shows FIL 200 is superior to FIL 100 or ADA 40. Drs. Fleischman/Genovese at #RWCS2020 @RWCSmtg https://t.co/rMLtnLK73B

Last day for #RWCS2020 in #Maui - Dr. Roy Fleischmann @UTSWNews and Dr. Mark Genovese @StanfordHealth talk updates on promising new molecules such as #upadacitinib https://t.co/VWYYO6gMpR https://t.co/drfWXpiPCs

• Rheumatology Winter Clinical Symposium

SELECT-COMPRE study shows that if you don't respond to either ADA or UPAD you can successfully switch to the other. Drs. Fleischman/Genovese at #RWCS2020 @RWCSmtg https://t.co/wKx1ceu50X

Talk on SAPHO includes dance from singer SAPHO. Way to go Anne Stevens #RWCS2020 @RheumNow PS SAPHO is synovitis acne pustulosis hyperostosis osteitis #RWCS2020 @RheumNow https://t.co/S3wVEtZ3OJ

A novel TYK2 inhibitor may provide clinicians with another treatment option along the janus kinase pathway in patients with severe #psoriasis, said Dr. George Martin at #RWCS2020 @RWCSmtg https://t.co/i630rfoxnl

• Novel TYK2 inhibitor may be a ‘game changer’ for psoriasis

Do you use MTX in your PsA patients with PsO? @RheumNow @RWCSmtg #RWCS2020

#RWCS2020 Day 3 kicks off with Dr. Eric Ruderman @NUFeinbergMed and Dr. Arthur Kavanaugh @UCSDHealth addressing #psoriaticarthritis developments, including #microbiome and #epigenomic connections to #psoriasis https://t.co/VWYYO6gMpR https://t.co/HkH31vUICG

• Rheumatology Winter Clinical Symposium

Is #telemedicine the future for #rheumatology or a potential legal nightmare? Dr. Alvin Wells @DukeHealth and Dr. Orrin Troum @KeckMedUSC square off on this new avenue for #patient care at #RWCS2020 https://t.co/VWYYO6gMpR https://t.co/Jb9uK5xPeg

• Rheumatology Winter Clinical Symposium

What is your “go to” treatment for skin dz in early dcSSc? Dr. Pope @RheumNow @RWCSmtg #RWCS2020

“Not all drugs get REMS (risk evaluation and mitigation strategies) or post marketing safety from the FDA.” Dr. Genovese. What does this mean for patients? What does this mean for us? #RWCS2020 @RheumNow @RWCSmtg

Is SAPHO the same thing as non bacterial focal osteomyelitis in kids? Maybe. Likely. Same bone sites involved. Rule out Tumor and infection. Anne Stevens #RWCS2020 @RheumNow https://t.co/HqlVgTXrSJ

Chickens in ...trees and beautiful Maui sunset at RWCS #Hawaii #RWCS2020 @RheumNow https://t.co/ci3c8gFrmR

“Auto ab, vascular damage and fibrosis is our SSc triad.” Dr. Pope @RheumNow @RWCSmtg #RWCS2020 https://t.co/kE7TMdQ3th

The 15% rule in scleroderma. Thanks, Dr. Janet Pope! #RWCS2020 https://t.co/mAvrZTOsGP